Structural basis of ubiquitylation

Current Opinion in Structural Biology

Volumn 12, Issue 6, 2002, Pages 822-830

  VanDemark, Andrew P ^a   Hill, Christopher P ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; ENZYME E2; ENZYME E3; PROTEIN; PROTEIN CUL1; PROTEIN SKP1; UBIQUITIN; UNCLASSIFIED DRUG;

CELL FUNCTION; CHEMICAL REACTION; CRYSTAL STRUCTURE; ENZYME CONFORMATION; EUKARYOTE; HYDROGEN BOND; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; UBIQUITINYLATION;

EUKARYOTA;

EID: 0036909263     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(02)00389-5     Document Type: Review

References (68)

1. Hershko A., Ciechanover A. The ubiquitin system. Annu Rev Biochem. 67:1998;425-479.
2. Hochstrasser M. All in the ubiquitin family. Science. 289:2000;563-564.
3. Pickart C.M. Mechanisms underlying ubiquitination. Annu Rev Biochem. 70:2001;505-533.
4. Pickart C.M. Ubiquitin in chains. Trends Biochem Sci. 25:2000;544-548.
5. Scheffner M., Nuber U., Huibregtse J.M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature. 373:1995;81-83.
6. Joazeiro C.A., Weissman A.M. RING finger proteins: mediators of ubiquitin ligase activity. Cell. 102:2000;549-552.
7. Kamura T., Koepp D.M., Conrad M.N., Skowyra D., Moreland R.J., Iliopoulos O., Lane W.S., Kaelin W.G.J., Elledge S.J., Conaway R.C., et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science. 284:1999;657-661.
8. Skowyra D., Koepp D.M., Kamura T., Conrad M.N., Conaway R.C., Conaway J.W., Elledge S.J., Harper J.W. Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1. Science. 284:1999;662-665.
9. Huang L., Kinnucan E., Wang G., Beaudenon S., Howley P.M., Huibregtse J.M., Pavletich N.P. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science. 286:1999;1321-1326.
10. Zheng N., Wang P., Jeffrey P.D., Pavletich N.P. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell. 102:2000;533-539. The primary substrate-binding site is seen to be 60 Å from the E2 catalytic cysteine, although the compact structure argues against a conformational change. The E2 binds c-Cbl through the same surface it uses to bind E6-AP, although the c-Cbl and E6-AP structures are quite different.
11. Bernier-Villamor V., Sampson D.A., Matunis M.J., Lima C.D. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin conjugating enzyme Ubc9 and RanGAP1. Cell. 108:2002;345-356. The structural basis is revealed for the recognition of SUMOylation substrates by the E2 Ubc9. The absence of titratable groups near the active site suggests that catalysis proceeds without the assistance of a base to enhance nucleophilicity of the lysine residue.
12. VanDemark A.P., Hofmann R.M., Tsui C., Pickart C.M., Wolberger C. Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer. Cell. 105:2001;711-720. This report, together with [57•], shows that a combination of structure determination and mutagenesis/biochemistry suggests that the acceptor ubiquitin is oriented for conjugation on Lys63 by binding in a channel formed at the interface of Ubc13 and Mms2.
13. Nuber U., Scheffner M. Identification of determinants in E2 ubiquitin-conjugating enzymes required for hect E3 ubiquitin-protein ligase interaction. J Biol Chem. 274:1999;7576-7582.
14. Aravind L., Koonin E.V. The U box is a modified RING finger-a common domain in ubiquitination. Curr Biol. 10:2000;R132-134. Sequence comparisons and modeling indicate a common fold for RING finger and U-box domains, despite replacement of RING zinc ion ligands with polar sidechains.
15. Koegl M., Hoppe T., Schlenker S., Ulrich H.D., Mayer T.U., Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell. 96:1999;635-644.
16. Cyr D.M., Hohfeld J., Patterson C. Protein quality control: U-box-containing E3 ubiquitin ligases join the fold. Trends Biochem Sci. 27:2002;368-375.
17. Wang G., Yang J., Huibregtse J.M. Functional domains of the Rsp5 ubiquitin-protein ligase. Mol Cell Biol. 19:1999;342-352.
18. Kanelis V., Rotin D., Forman-Kay J.D. Solution structure of a Nedd4 WW domain-ENaC peptide complex. Nat Struct Biol. 8:2001;407-412.
19. Kussie P.H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A.J., Pavletich N.P. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. 274:1996;948-953.
20. Meng W., Sawasdikosol S., Burakoff S.J., Eck M.J. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature. 398:1999;84-90.
21. Kobe B., Kajava A.V. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol. 11:2001;725-732.
22. Smith T.F., Gaitatzes C., Saxena K., Neer E.J. The WD repeat: a common architecture for diverse functions. Trends Biochem Sci. 24:1999;181-185.
23. Jackson P.K., Eldridge A.G., Freed E., Furstenthal L., Hsu J.Y., Kaiser B.K., Reimann J.D. The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends Cell Biol. 10:2000;429-439.
24. Yoshida Y., Chiba T., Tokunaga F., Kawasaki H., Iwai K., Suzuki T., Ito Y., Matsuoka K., Yoshida M., Tanaka K., et al. E3 ubiquitin ligase that recognizes sugar chains. Nature. 418:2002;438-442.
25. Polekhina G., House C.M., Traficante N., Mackay J.P., Relaix F., Sassoon D.A., Parker M.W., Bowtell D.D. Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling. Nat Struct Biol. 9:2002;68-75.
26. Reed J.C., Ely K.R. Degrading liaisons: Siah structure revealed. Nat Struct Biol. 9:2002;8-10.
27. Epstein A.C.R., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:2001;43-54.
28. 2 sensing. Science. 292:2001;464-468.
29. 2-regulated prolyl hydroxylation. Science. 292:2001;468-472.
30. Min J.H., Yang H., Ivan M., Gertler F., Kaelin W.G.J., Pavletich N.P. Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling. Science. 296:2002;1886-1889. This report, together with [31••], shows that pVHL specifically binds a Hyp residue of its HIF-1α substrate through two hydrogen bonds at the bottom of a hydrophobic pocket. Surface plasmon resonance confirmed the role of individual residues in binding suggested by the crystal structure.
31. Hon W.C., Wilson M.I., Harlos K., Claridge T.D., Schofield C.J., Pugh C.W., Maxwell P.H., Ratcliffe P.J., Stuart D.I., Jones E.Y. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature. 417:2002;975-978. See annotation to [30••].
32. Stebbins C.E., Kaelin W.G.J., Pavletich N.P. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science. 284:1999;455-461.
33. Kipreos ET, Pagano M: The F-box protein family. Genome Biol 2000, 1:3002.3001-3002.30007.
34. Kile B.T., Schulman B.A., Alexander W.S., Nicola N.A., Martin H.M., Hilton D.J. The SOCS box: a tale of destruction and degradation. Trends Biochem Sci. 27:2002;235-241.
35. Alexander W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol. 2:2002;410-416.
36. Kamura T., Sato S., Haque D., Liu L., Kaelin W.G.J., Conaway R.C., Conaway J.W. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 15:1998;3872-3881.
37. Schulman B.A., Carrano A.C., Jeffrey P.D., Bowen Z., Kinnucan E.R., Finnin M.S., Elledge S.J., Harper J.W., Pavletich N.P. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature. 408:2000;381-386. The Skp2 F-box binds Skp1 through core and variable interfaces. The F-box and substrate-binding domain of Skp2 are packed against each other, rather than being connected through a flexible tether.
38. Zheng N., Schulman B.A., Song L., Miller J.J., Jeffrey P.D., Wang P., Chu C., Koepp D.M., Elledge S.J., Pagano M., et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature. 416:2002;703-709. The cullin Cul1 is shown to have an elongated structure that binds Skp1-F-box-substrate at its N-terminal end and the RING subunit at its C-terminal end. A model is proposed for how the substrate is presented to the E2.
39. Shirane M., Harumiya Y., Ishida N., Hirai A., Miyamoto C., Hatakeyama S., Nakayama K., Kitagawa M. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem. 274:1999;13886-13893.
40. Gieffers C., Dube P., Harris J.R., Stark H., Peters J.M. Three-dimensional structure of the anaphase-promoting complex. Mol Cell. 7:2001;907-913.
41. Margottin F., Bour S.P., Durand H., Selig L., Benichou S., Richard V., Thomas D., Strebel K., Benarous R. A novel human WD protein, h-βTrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell. 1:1998;565-574.
42. Stone D.M., Murone M., Luoh S., Ye W., Armanini M.P., Gurney A., Phillips H., Brush J., Goddard A., de Sauvage F.J., et al. Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J Cell Sci. 112:1999;4437-4448.
43. Ganoth D., Bornstein G., Ko T.K., Larsen B., Tyers M., Pagano M., Hershko A. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol. 3:2001;321-324.
44. Spruck C., Strohmaier H., Watson M., Smith A.P., Ryan A., Krek T.W., Reed S.I. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell. 7:2001;639-650.
45. Kitagawa K., Skowyra D., Elledge S.J., Harper J.W., Hieter P. SGT1 encodes an essential component of the yeast kinetochore assembly pathway and a novel subunit of the SCF ubiquitin ligase complex. Mol Cell. 4:1999;21-33.
46. Azevedo C., Sadanandom A., Kitagawa K., Freialdenhoven A., Shirasu K., Schulze-Lefert P. The RAR1 interactor SGT1, an essential component of R gene-triggered disease resistance. Science. 295:2002;2073-2076.
47. Wendt K.S., Vodermaier H.C., Jacob U., Gieffers C., Gmachl M., Peters J.M., Huber R., Sondermann P. Crystal structure of the APC10/DOC1 subunit of the human anaphase-promoting complex. Nat Struct Biol. 8:2001;784-788.
48. Au S.W., Leng X., Harper J.W., Barford D. Implications for the ubiquitination reaction of the anaphase-promoting complex from the crystal structure of the Doc1/Apc10 subunit. J Mol Biol. 316:2002;955-968.
49. Hwang L.H., Murray A.W. A novel yeast screen for mitotic arrest mutants identifies DOC1, a new gene involved in cyclin proteolysis. Mol Biol Cell. 8:1997;1877-1887.
50. Kominami K., Seth-Smith H., Toda T. Apc10 and Ste9/Srw1, two regulators of the APC-cyclosome, as well as the CDK inhibitor Rum1 are required for G1 cell-cycle arrest in fission yeast. EMBO J. 17:1998;5388-5399.
51. Grossberger R., Gieffers C., Zachariae W., Podtelejnikov A.V., Schleiffer A., Nasmyth K., Mann M., Peters J.M. Characterization of the DOC1/APC10 subunit of the yeast and the human anaphase-promoting complex. J Biol Chem. 274:1999;14500-14507.
52. Luo X., Fang G., Coldiron M., Lin Y., Yu H., Kirschner M.W., Wagner G. Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20. Nat Struct Biol. 7:2000;224-229.
53. Luo X., Tang Z., Rizo J., Yu H. The Mad2 spindle checkpoint protein undergoes similar major conformational changes upon binding to either Mad1 or Cdc20. Mol Cell. 9:2002;59-71.
54. Sironi L., Mapelli M., Knapp S., De Antoni A., Jeang K.T., Musacchio A. Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding mechanism for the spindle checkpoint. EMBO J. 21:2002;2496-2506.
55. Hofmann R.M., Pickart C.M. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell. 96:1999;645-653.
56. Hoege C., Pfander B., Moldovan G.L., Pyrowolakis G., Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature. 419:2002;135-141.
57. Moraes T.F., Edwards R.A., McKenna S., Pastushok L., Xiao W., Glover J.N., Ellison M.J. Crystal structure of the human ubiquitin conjugating enzyme complex, hMms2-hUbc13. Nat Struct Biol. 8:2001;669-673. See annotation to [12••].
58. Katzmann D.J., Babst M., Emr S.D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell. 106:2001;145-155.
59. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 107:2001;55-65.
60. Martin-Serrano J., Zang T., Bieniasz P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med. 7:2001;1313-1319.
61. VerPlank L., Bouamr F., LaGrassa T.J., Agresta B., Kikonyogo A., Leis J., Carter C.A. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci USA. 98:2001;7724-7729.
62. Pornillos O., Alam S.L., Rich R.L., Myszka D.G., Davis D.R., Sundquist W.I. Structure and functional interactions of the Tsg101 UEV domain. EMBO J. 21:2002;2397-2406. Compared to canonical E2s, the Tsg101 UEV has an extended β hairpin that links strands 1 and 2, and lacks the two C-terminal helices. PTAP-containing peptides bind in a hydrophobic cleft exposed by the absence of the C-terminal helices and ubiquitin binds in a novel site surrounding the β hairpin.
63. Pornillos O., Alam S.L., Davis D.R., Sundquist W.I. Structure of the Tsg101 UEV domain in complex with its peptide binding site in the HIV-1 p6 protein. Nat Struct Biol. 9:2002;812-817.
64. Melchior F. SUMO-nonclassical ubiquitin. Annu Rev Cell Dev Biol. 16:2000;591-626.
65. Miura T., Klaus W., Gsell B., Miyamoto C., Senn H. Characterization of the binding interface between ubiquitin and class I human ubiquitin-conjugating enzyme 2b by multidimensional heteronuclear NMR spectroscopy in solution. J Mol Biol. 290:1999;213-228.
66. Hamilton K.S., Ellison M.J., Barber K.R., Williams R.S., Huzil J.T., McKenna S., Ptak C., Glover M., Shaw G.S. Structure of a conjugating enzyme-ubiquitin thiolester intermediate reveals a novel role for the ubiquitin tail. Structure. 9:2001;897-904.
67. Matsuzawa S.I., Reed J.C. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell. 7:2001;915-926.
68. Liu J., Stevens J., Rote C.A., Yost H.J., Hu Y., Neufeld K.L., White R.L., Matsunami N. Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell. 7:2001;927-936.